Evaluation of factors affecting visit adherence in patients receiving intravitreal injections for neovascular age-related macular degeneration during the COVID-19 Pandemic

被引：0
|
作者：
Dong, Kaylin [1 ]
Bains, Ashank [1 ]
Davoudi, Samaneh [1 ]
Nguyen, Anh Hong [1 ]
Chen, Xuejing [1 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
331-F0162
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinical outcomes in neovascular age-related macular degeneration: a cohort study of patients with care delay due to the COVID-19 pandemic
    Timothy M. Janetos
    Roya Zandi
    David Younessi
    Gina Johnson
    Amber Randolph
    Manjot Gill
    Scientific Reports, 13
  • [32] Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection for Refractory Neovascular Age-Related Macular Degeneration
    Kim, Yung-Hwi
    Moon, Tae Kyu
    Ji, Yong-Sok
    OPHTHALMOLOGY AND THERAPY, 2024, : 2679 - 2695
  • [33] TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration
    Montesel, Andrea
    Gigon, Anthony
    Giacuzzo, Clarice
    Mantel, Irmela
    Eandi, Chiara M.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (04): : 634 - 642
  • [34] The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens
    Bo Jiang
    Lin Gao
    Su Dong
    Qingxue Hou
    Minghao Sun
    Jingjie Zhang
    Haotian Yu
    Zhongyu Zhang
    Dawei Sun
    Advances in Therapy, 2022, 39 : 1568 - 1581
  • [35] Evaluating the Influence of Sociodemographic Factors on Vis Adherence for Patients with Neovascular Age-Related Macular Degeneration
    Choi, Alison
    Nawash, Baraa S.
    Ong, Joshua
    Sahel, Jose Alain
    Chhablani, Jay
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [36] PROGNOSTIC FACTORS AND OUTCOME OF INTRAVITREAL RANIBIZUMAB TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Narayan, Daniel
    Meucke, James
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 113 - 113
  • [37] Glaucoma progression in patients receiving intravitreal anti-VEGF treatment for neovascular age-related macular degeneration
    Pirinen, Inka
    Leinonen, Sanna
    Helminen, Mika
    Hujanen, Pekko
    Vaajanen, Anu
    Tuulonen, Anja
    Uusitalo-Jaervinen, Hannele
    ACTA OPHTHALMOLOGICA, 2023, 101 (03) : 261 - 265
  • [38] GENETIC FACTORS ASSOCIATED WITH RESPONSE TO INTRAVITREAL RANIBIZUMAB IN KOREAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Park, Un Chul
    Shin, Joo Young
    Kim, Sang Jin
    Shin, Eun Soon
    Lee, Jong Eun
    McCarthy, Linda C.
    Newcombe, Paul J.
    Xu, Chun-Fang
    Chung, Hum
    Yu, Hyeong Gon
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (02): : 288 - 297
  • [39] Clinical Evaluation of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections in Subjects with Neovascular Age-Related Macular Degeneration
    Csaky, Karl G.
    Dugel, Pravin U.
    Pierce, Amy J.
    Fries, Michael A.
    Kelly, Deborah S.
    Danis, Ronald P.
    Wurzelmann, John I.
    Xu, Chun-Fang
    Hossain, Mohammad
    Trivedi, Trupti
    OPHTHALMOLOGY, 2015, 122 (03) : 579 - 588
  • [40] Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab
    Allegrini, Davide
    Raimondi, Raffaele
    Montesano, Giovanni
    Borgia, Alfredo
    Sorrentino, Tania
    Tsoutsanis, Panagiotis
    Romano, Mario R.
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 4073 - 4079
12345